Brazil Equity Surge
Brazilian stocks are seeing a massive, coordinated rally. High volume across these names suggests institutional capital is aggressively rotating into the region.
On 5 October 2026 101 of the 175 instruments Kinzan measured closed the 24 hours higher and 56 lower, with the risk dial at 59 of 100 (mixed). Of the instruments Kinzan tracks, Algorand trailed at −2.42%.
Risk appetite is broad-based, fueled by a massive rally in Brazilian equities and biotech stocks, while commodities show mixed volatility and the dollar remains under pressure.
The focus has shifted from general volatility to a concentrated, high-momentum rally in Brazilian stocks and specific biotech names.
"Since" is close-to-close from this day to the latest daily close
| Instrument | That day | Surprise | Since |
|---|---|---|---|
| Algorand ALGO | −2.42% | −0.5σ | −16.41% |
| WTI Crude Oil WTI | −1.99% | −0.7σ | +11.10% |
On the board because they moved — not instruments Kinzan tracks, so no surprise figure and no page
Brazilian stocks are seeing a massive, coordinated rally. High volume across these names suggests institutional capital is aggressively rotating into the region.
Biotech stocks are dominating the leaderboard with extreme volatility and massive daily gains. Traders are chasing high-beta names, ignoring traditional valuation metrics.
A clear pattern of New York session buying is pushing multiple assets to the top of their daily ranges. This suggests strong late-day conviction.
Commodities are moving in opposite directions, with gasoline breaking down while sugar and juice hit daily highs. Volatility is significantly higher than normal for energy products.
Emerging market currencies like the CLP and COP are showing unusual strength against the dollar. This is creating clear, one-sided trends in forex pairs.